Upstream Medical Technologies Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Liquidation
Upstream Medical Technologies General Information
Description
Operator of a medical diagnostics company intended to help clients detect cardiovascular diseases. The company's cardioendocrine bio-markers diagnose a range of conditions in heart disease and associated complications, enabling doctors to detect and treat heart disease without causing much harm to the patient.
Contact Information
Website
www.upstreamdx.comCorporate Office
- 55 Shortland Street
- The Shortland Centre, Level 5
- Auckland, 1010
- New Zealand
Corporate Office
- 55 Shortland Street
- The Shortland Centre, Level 5
- Auckland, 1010
- New Zealand
Upstream Medical Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Bankruptcy: Liquidation | 02-Sep-2025 | Completed | Bankruptcy: Liquidation | |||
| 8. Later Stage VC | 04-May-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 09-Jun-2022 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 13-May-2019 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | 15-Jan-2018 | Completed | Startup | |||
| 4. Seed Round | 13-Nov-2017 | Completed | Startup | |||
| 3. Angel (individual) | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Upstream Medical Technologies Patents
Upstream Medical Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023548961-A | Novel biomarker for acute coronary syndrome | Pending | 23-Oct-2020 | ||
| AU-2021365602-A1 | Novel biomarker of acute coronary syndromes | Inactive | 23-Oct-2020 | ||
| CA-3195863-A1 | Novel biomarker of acute coronary syndromes | Pending | 23-Oct-2020 | ||
| EP-4232826-A1 | Novel biomarker of acute coronary syndromes | Inactive | 23-Oct-2020 | ||
| EP-4232826-A4 | Novel biomarker of acute coronary syndromes | Inactive | 23-Oct-2020 | G01N33/6893 |
Upstream Medical Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Upstream Medical Technologies FAQs
-
When was Upstream Medical Technologies founded?
Upstream Medical Technologies was founded in 2015.
-
Where is Upstream Medical Technologies headquartered?
Upstream Medical Technologies is headquartered in Auckland, New Zealand.
-
What is the size of Upstream Medical Technologies?
Upstream Medical Technologies has 7 total employees.
-
What industry is Upstream Medical Technologies in?
Upstream Medical Technologies’s primary industry is Diagnostic Equipment.
-
Is Upstream Medical Technologies a private or public company?
Upstream Medical Technologies is a Private company.
-
What is Upstream Medical Technologies’s current revenue?
The current revenue for Upstream Medical Technologies is .
-
How much funding has Upstream Medical Technologies raised over time?
Upstream Medical Technologies has raised $12.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
